NewGenIVF Terminates Merger Plans with European Wellness
BANGKOK — NewGenIvf Group Limited (NASDAQ: NIVF), a known fertility service provider in Asia, has recently announced the termination of its proposed reverse merger with European Wellness Investment Holdings Limited (EWIHL). This decision comes as a result of EWIHL's failure to deliver necessary draft audited financial statements by the stipulated deadline.
The journey began on December 11, 2024, when NewGen entered into a binding agreement that would see EWIHL acquiring approximately 61.6% of NewGen’s equity post-transaction. However, this plan has come to a halt due to unmet conditions that were crucial for the transaction's completion.
According to NewGen's management, the required draft audited financials for the 2023 and 2024 financial years were not submitted by the March 31 deadline. As per their rights under the binding term sheet, NewGen has opted to terminate the transaction without incurring any costs. The company is now looking to redirect its focus to existing initiatives that promise greater growth potential.
Leadership Remarks on Future Directions
CEO Mr. Siu Wing Fung Alfred expressed confidence in NewGen’s future, stating, “While the proposed transaction with EWIHL will not move forward as planned, we remain confident in our ability to drive success through other avenues in the market.” This sentiment reflects NewGen’s commitment to explore other opportunities beyond the merger.
Focus on Core Business Strategy
Despite the setback of the terminated merger, the company is keen to continue executing its core business strategy. The management team has identified various growth avenues, emphasizing the potential of their recent acquisition of Microsort and the introduction of their egg-freezing service.
Commitment to Fertility Services
NewGenIVF is dedicated to enhancing access to fertility treatments for couples and individuals facing reproductive challenges. The company provides a comprehensive array of services, including assisted reproductive technology, egg and sperm donation, and surrogacy across its clinics in Thailand, Cambodia, and Kyrgyzstan. With their experienced management team, NewGen aims to position itself as a leader in the fertility market, continuously extending their innovative services.
About NewGenIVF
NewGenIVF stands out as a holistic fertility service provider that strives to assist individuals and couples in overcoming the various hurdles of infertility. With an unwavering mission to support families in their journey, NewGen offers a full suite of fertility services. Their extensive experience in the fertility sector equips them to navigate the intricacies of reproductive health and to cater effectively to their clients’ needs.
Frequently Asked Questions
What led to the termination of the merger with EWIHL?
The merger was terminated due to EWIHL’s failure to provide the required audited financial statements by the set deadline, allowing NewGen to exercise its right to end the transaction.
How does this impact NewGenIVF's growth plans?
Despite the merger termination, NewGenIVF remains focused on its existing operations and is exploring opportunities like its Microsort acquisition and egg-freezing service to foster growth.
What services does NewGenIVF provide?
NewGenIVF provides a wide range of fertility services, including assisted reproductive technologies, egg and sperm donation, and surrogacy options.
Where are NewGenIVF’s clinics located?
The clinics are situated across Thailand, Cambodia, and Kyrgyzstan, allowing them to serve a broad client base in the region.
Who is leading NewGenIVF?
Mr. Siu Wing Fung Alfred serves as the Founder, Chairman, and CEO, leading the company with a vision of growth and excellence in fertility services.
